Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial. (PubMed, Ann Rheum Dis) - Sep 23, 2026 - "Our model estimates the risk of first relapse for individuals with AAV within 2 years after achieving disease remission. This may inform monitoring and treatment decisions. The model will benefit from future external validation."
Journal • ANCA Vasculitis • Vasculitis
|
|
; Christian Pagnoux; David Jayne; David Massicotte-Azarniouch; Eswari Vilayur; Louis Girard; Mats Junek; Michael Walsh; Nader Khalidi; Peter A Merkel; Quazi Ibrahim; Ron Wald; Todd Fairhead
|